Purchase Order 75D30120P08014
- Not listed
- This federal contract award is for the delivery of supplies to support the Centers for Disease Control and Prevention's (CDC) National Antimicrobial Resistance Monitoring System (NARMS) program. The prime contractor is Remel Inc., doing business as Thermo Fisher Scientific Remel Products, a manufacturer of microbiology laboratory products and diagnostic test kits. The contract, valued at $144,305.14, is a firm fixed-price delivery order awarded by the Department of Health and Human Services'...
- This federal contract award to Remel Inc., doing business as Thermo Fisher Scientific Remel Products, is for the provision of supplies to the U.S. Food and Drug Administration (FDA) for the National Antimicrobial Resistance Monitoring System (NARMS) and other programs. The firm-fixed-price delivery order, valued at $101,150.05, does not have a small business set-aside designation. Remel Inc. is a for-profit manufacturer of microbiology laboratory products and diagnostic test kits, and a...
- This federal contract award provides Remel Inc., a subsidiary of Thermo Fisher Scientific, with a $96,502.48 firm-fixed-price delivery order to supply antimicrobial susceptibility testing systems, reagents, and specialized scientific instrumentation for the National Antimicrobial Resistance Monitoring System (NARMS) contract. The award was made by the Office of Administrative Services Procurement Management Branch, a civilian federal agency. Remel Inc. is an established provider of...
- This federal contract award, with an ID of HHSD2002017M93886P, was issued by the Centers for Disease Control and Prevention (CDC) to Remel Inc., a subsidiary of Thermo Fisher Scientific. The $88,730.80 firm fixed-price contract is for the procurement of Susceptibility Supplies for the Sensititre System, which are likely laboratory supplies and equipment used in antimicrobial susceptibility testing. Remel Inc. is a for-profit manufacturer of microbiology products and diagnostic test kits that has...
- This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to Remel Inc., a subsidiary of Thermo Fisher Scientific, for the provision of microbiology laboratory products and diagnostic test kits. The contract, valued at $96,720.00, is a firm fixed-price purchase order with a completion date of September 30, 2021. The award is not associated with a set-aside designation. Remel Inc. is a major supplier of scientific equipment and supplies, including...
- The Department of Health and Human Services Food and Drug Administration awarded a $135,635.60 firm-fixed-price delivery order contract to Remel Inc., doing business as Thermo Fisher Scientific Remel Products, for the provision of laboratory supplies in support of the National Antimicrobial Resistance Monitoring System (NARMS) program. Remel Inc. is a manufacturer of microbiology products and diagnostic test kits that has previously provided various scientific supplies and testing services to...
- This federal contract award, valued at $97,100.00, was issued by the Centers for Disease Control and Prevention (CDC) to Remel Inc., a foreign-owned, for-profit manufacturer of microbiology laboratory products and diagnostic test kits doing business as Thermo Fisher Scientific Remel Products. The contract is for SENSITITRE ARIS HIQ and POWERVAR SOLUTIONS, with a completion date of November 30, 2022. It is a firm fixed-price purchase order contract with no set-aside designation. Remel is a...
- Remel Inc., operating under the Thermo Fisher Scientific brand, received a delivery order contract award from the Office of Administrative Services Procurement Management Branch on March 18, 2015, for the supply of National Antimicrobial Resistance Monitoring System (NARMS) supplies spanning March through September 2015. The contract, valued at approximately $69.3K with firm fixed pricing, had an ultimate completion date of September 30, 2016, and did not utilize a small business set-aside...
- This federal contract award, valued at $68,046.25, was issued by the Food and Drug Administration (FDA) to Remel Inc., a subsidiary of Thermo Fisher Scientific that manufactures microbiology laboratory products and diagnostic test kits. The contract is for the FY24 delivery of various NARMS (National Antimicrobial Resistance Monitoring System) REMEL supplies compatible with SENSITITRE equipment at two locations. This is a firm-fixed-price delivery order contract with a completion date of...
- This federal contract award to Remel Inc., a subsidiary of Thermo Fisher Scientific, is a $76,154.12 firm-fixed-price purchase order from the National Institutes of Health (NIH) Clinical Center. The contract supports the provision of microbiology laboratory products and diagnostic test kits, including Sensititre antimicrobial susceptibility testing systems, viral transport media, blood culture media, real-time PCR systems, and specialized laboratory reagents. Remel Inc. has established itself as...
This federal contract award to Remel Inc., a subsidiary of Thermo Fisher Scientific, provides laboratory equipment maintenance services for the National Antimicrobial Resistance Monitoring System (NARMS) Sensititre program. The $76,645.72 fixed-price contract was awarded by the Centers for Disease Control and Prevention (CDC) to support the agency's public health and food safety initiatives. Remel Inc. is a manufacturer of microbiology laboratory products and diagnostic test kits, specializing in antimicrobial susceptibility testing systems, viral transport media, and specialized scientific instrumentation. The contract does not include a small business set-aside designation. Thermo Fisher Scientific, the parent company of Remel Inc., is an established federal contractor providing a range of scientific instruments and services to agencies such as the Department of Health and Human Services, Department of Defense, and Environmental Protection Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 9/13/23 | |
| Not listed | Not listed | $38.3k | 4/22/20 |